08/11/2026
Dementia is devastating – but research gives us reasons to be hopeful.
More than 150 Alzheimer’s disease drugs are in clinical trials today, and we continue to hear from researchers about promising new treatments being developed.
Around 1,600 people will take part in a trial to find out whether a drug called trontinemab could delay or prevent Alzheimer’s symptoms from ever developing.
Advances in blood tests and brain imaging are bringing researchers closer to more personalised diagnosis and treatment, with blood tests showing promise for helping more people receive an earlier and more accurate diagnosis of Alzheimer's disease.
While there’s no guaranteed way to prevent dementia, a large study suggested that healthy lifestyle choices may benefit brain health regardless of a person's genetic risk of Alzheimer's disease.
And in the US, a self-injectable form of lecanemab, a treatment that can slow the progression of early Alzheimer's disease in eligible people, has been approved. While not available in the UK currently, this progress shows that self-injectable treatments could be part of how we treat dementia in the future.
We work with world-leading scientists and people affected by dementia to make sure the research we fund is the highest quality and addresses the highest-priority issues.
Because we know that through research we will make breakthroughs in how we understand the causes of dementia, develop effective treatments, improve care, and ultimately, one day, find a cure.
